Leading BioSolutions Platform

Our response to supply challenges from China Supply challenges from China Frequent supply disruptions UPL UPL response Uncertainty Rising costs due to capacity closure and increased compliance Definitive steps on increased in-house manufacturing in India Strategic partnership with other manufacturing players Extra tariffs on supplies to US Strong relationship management with good, stable Chinese suppliers 21

View entire presentation